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Abstract
Background: Different types of membrane microdomains (rafts) have been postulated to be present in the rear
and front of polarized migrating T-lymphocytes. Disruption of rafts by cholesterol sequestration prevents T-cell
polarization and migration. Reggie/flotillin-1 and -2 are two highly homologous proteins that are thought to shape
membrane microdomains. We have previously demonstrated the enrichment of flotillins in the uropod of human
neutrophils. We have now investigated mechanisms involved in chemokine-induced flotillin reorganization in
human T-lymphocytes, and possible roles of flotillins in lymphocyte polarization.
Results: We studied flotillin reorganization and lateral mobility at the plasma membrane using
immunofluorescence staining and FRAP (fluorescence recovery after photobleaching). We show that flotillins
redistribute early upon chemokine stimulation, and form very stable caps in the uropods of human peripheral
blood T-lymphocytes, colocalizing with the adhesion molecule PSGL-1 and activated ezrin/radixin/moesin (ERM)
proteins. Chemokine-induced formation of stable flotillin caps requires integrity and dynamics of the actin
cytoskeleton, but is not abolished by inhibitors suppressing Rho-kinase or myosin II activity. Tagged flotillin-2 and
flotillin-1 coexpressed in T-lymphocytes, but not singly expressed proteins, colocalize in stable caps at the tips of
uropods. Lateral mobility of coexpressed flotillins at the plasma membrane is already partially restricted in the
absence of chemokine. Incubation with chemokine results in almost complete immobilization of flotillins. Capping
is abolished when wild-type flotillin-1 is coexpressed with a mutant of flotillin-2 (G2A) that is unable to interact
with the plasma membrane, or with a deletion mutant of flotillin-2 that lacks a putative actin-binding domain.
Wild-type flotillin-2 in contrast forms caps when coexpressed with a mutant of flotillin-1 unable to interact with
membranes. Transfection of T-lymphocytes with flotillin-2-G2A reduces cell polarization and uropod recruitment of
endogenous flotillin-1 and PSGL-1.
Conclusions: Our data suggest that stable flotillin cap formation in the rear of polarized T-lymphocytes requires
flotillin heterooligomer formation, as well as direct F-actin interactions of flotillin-2 and raft/membrane association
of flotillin-2, but not -1. Our data also implicate flotillin-rich actin-dependent membrane microdomains in T-
lymphocyte uropod formation.
Background
Adaptive immune cells such as T-cells, continuously tra-
vel through the tissues, using amoeboid locomotion.
This enables these cells to rapidly recognize foreign
antigens, to stimulate antibody production and to
destroy virally infected cells or tumor cells. T-cell polari-
zation and directional migration is a complex, not yet
well understood process. Certainly it involves a func-
tional cytoskeleton, reversible actin polymerization in
the front and myosin-dependent contractility in the rear
of a migrating, polarized cell [1-3].
Polarization of leukocytes requires segregation and
activation of specific signaling and cytoskeletal mole-
cules in the retracting rear (uropod) and motile forward
moving part (front) of the cells [4]. Localized positive
feedback loops and inhibitory effects of front signaling
pathways on rear signaling and vice versa are thought to
reinforce this biochemical and structural cell polariza-
tion [5]. The compartmentalization of signaling mole-
cules could be stabilized by formation of plasma * Correspondence: verena.niggli@pathology.unibe.ch
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organize signaling systems in the membrane [6].
Interestingly current evidence suggests the presence of
different types of membrane microdomains in the front
and tail of polarized migrating leukocytes. The raft-resi-
dent lipid GM1 ganglioside is clustered in the tail of
polarized migrating T-lymphocytes and neutrophils,
whereas another raft marker, the ganglioside GM3, is
present in the front of these cells [6]. Experiments using
depletion of cellular cholesterol by treating cells with
methyl-b-cyclodextrin (MbCD) indicate indeed a crucial
role for cholesterol-dependent rafts in neutrophil and T-
lymphocyte polarization and migration [7-9]. However
little is known on raft organization in migrating
leukocytes.
Reggie/flotillin-1 and -2 are two highly homologous
proteins whose enrichment in membrane microdomains
has been ubiquitously observed. Flotillins, peripheral
membrane-associated proteins, are thought to be
involved in structuring membrane microdomains and
have been implicated in the delivery of membranes and
membrane proteins to cell contact sites, regenerating
axons, growth cones etc [10,11]. Flotillins are thus
attractive candidates for the structuring of membrane
microdomains in T-cells that lack caveolins. Membrane-
associated caps of flotillins have been observed in T-cell
lines such as Jurkat cells, human T lymphoblasts and
monocytes [12-14]. However the functional role of flotil-
lins in T-cell migration has not yet been explored except
for the report by Giri et al. [15] which suggests a role of
flotillin-1 in chemotaxis, adhesion, calcium mobilization
and Rac activation in freshly isolated human T-cells.
The role of flotillin-2 was not addressed in this study.
We have recently shown that flotillin-1 and -2 interact
and, upon stimulation with chemotactic peptide, rapidly
form membrane caps and at later time points accumu-
late in the uropods of polarized primary human neutro-
phils, preceding capping of other uropod proteins such
as ezrin/radixin/moesin (ERM). Capping of endogenous
flotillins in human neutrophils depends on actin
dynamics but does not require myosin II activity. Flotil-
lin capping and redistribution to the uropod matches
temporally and spatially that of P-selectin glycoprotein
ligand 1 (PSGL-1), and flotillins interact with PSGL-1 in
primary human neutrophils. PSGL-1 is not required for
t h ec a p p i n go ff l o t i l l i n s[ 1 6 ] .T h i sw o r ks u g g e s t sa n
important role of flotillins in structuring the neutrophil
uropod. Recent work by Ludwig et al. using neutrophils
from flotillin 1 knockout mice confirmed and extended
our work, showing that the lack of flotillin-1, which
leads to a reduction of flotillin-2 and its displacement
from rafts, results in impairment of murine neutrophil
uropod formation and migration through matrigel [17].
We have now studied mechanisms of reorganization of
flotillins in polarizing T-lymphocytes. We provide novel
data on the regulation of stimulus-dependent uropod
recruitment of flotillins by the cytoskeleton and by raft-
association, on the stimulus-dependent immobilization
of flotillins and on the functional roles of these proteins
in polarization of T-lymphocytes.
Methods
Materials
Materials and suppliers: stromal cell-derived factor 1
(SDF-1 = CXCL12): Peprotech, Paris, France. Y-27632,
Jasplakinolide: Calbiochem, Darmstadt, Germany.
Latrunculin A: Alexis Biochemicals, Switzerland. Bleb-
bistatin: Tocris Bioscience, UK. Bovine serum albumin
(BSA): Serva, Germany. Lysolecithin (L-a-lysophosphati-
dylcholine): Sigma. Ficoll-Paque™ Plus: GE Healthcare
Bio-Sciences AB, Uppsala, Sweden. Gey’ss o l u t i o nc o n -
tained 138 mM NaCl, 6 mM KCl, 1 mM MgSO4,1 . 1
mM CaCl2, 100 μME G T A ,1m MN a 2HPO4,5m M
NaHCO3, 5.5 mM glucose and 20 mM HEPES (pH 7.4).
Antibodies
A polyclonal anti-CD3 antibody (Cat. No. RM-9107) was
obtained from NeoMarkers, Fremont, CA, USA. Polyclo-
nal anti-phospho Ezrin (Thr567)/ Radixin (Thr564)/
Moesin (Thr558) antibody (Cat. No. 3141S) was from
Cell Signaling, MA, USA. Polyclonal anti-flotillin-2 (Cat.
No. sc-25507) was from Santa Cruz Biotechnology,
USA. A monoclonal anti-actin antibody (Cat. No.
010056) was from Bio-Science Products AG, Switzer-
land. Monoclonal murine antibodies directed against flo-
tillin-1 (Cat. No. F65020), flotillin-2 (Cat. No. E35820)
and PSGL-1 (Cat. No. 556053) were obtained from
Transduction Laboratories/BD Pharmingen, Germany. A
monoclonal murine antibody directed against the pro-
tein tag YPYDVPDYA (HA) (Cat. No. H9658) was
obtained from Sigma, and a polyclonal rabbit anti-HA
antibody (Cat. No. 561) was obtained from MBL, Japan.
The Alexa 488-conjugated goat-anti-rabbit (Cat. No.
A11008), Alexa-568-conjugated goat anti-rat (Cat. No.
A11077) and goat anti-mouse IgG antibodies (Cat. No.
A11001) were from Molecular Probes, OR, USA.
Isolation and culture of human T-lymphocytes
Peripheral blood lymphocytes were isolated from buffy
coats of healthy donor blood (Central Laboratory of the
Swiss Red Cross, Bern, Switzerland). Buffy coats were
diluted 1:4 with phosphate-buffered saline (PBS) lacking
calcium and magnesium. 30 ml of this suspension was
layered over 15 ml of Ficoll-Paque™ Plus and centri-
fuged at 500 × g for 25 minutes at room temperature.
The mononuclear cell layer was removed, washed in
Hank’sb u f f e r e ds a l ts o l u t i o na n dr e s u s p e n d e di nR P M I
containing 10% fetal calf serum (FCS) (4 × 10
6 cells/
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Page 2 of 17ml). Cells were activated for 2 days by culturing with 1
μg/ml phytohemagglutinin (PHA), followed by culturing
for 5 more days in fresh RPMI containing 50 U/ml IL-2.
These cells are referred to as “T-lymphoblasts”. T-lym-
phoblasts were used between day 7 and 20 after isola-
tion from the buffy coats. The preparations contained >
86% CD3-positive cells. Prior to some experiments,
when indicated in the figure legends, T-lymphoblasts
were incubated in culture medium lacking IL-2 at 37°C
for 14-18 hours. Medium was changed every 2-3 days.
For some experiments, freshly isolated T-lymphocytes
were used as indicated. These cells were isolated from
buffy coats using the Pan T Cell Isolation Kit II (Milte-
nyi Biotec) and separation on LD columns (Miltenyi
Biotec) according to the manufacturers instructions.
Briefly, mononuclear cells obtained from buffy coats as
described above were incubated with a cocktail of bio-
tin-conjugated antibodies against CD14, CD16, CD19,
CD36, CD56, CD123, and CD235a (glycophorin A).
These cells were subsequently depleted from the cell
suspension using anti-biotin MicroBeads. The resulting
cell suspension contained >95% T-lymphocytes as
assessed using anti-CD3 staining. The cells were used
after over night incubation in RPMI with 10% FCS at
37°C and 5% CO2.
Immunofluorescence staining
Cells were incubated in suspension in plastic tubes in
Gey’s buffer lacking calcium and magnesium at 37°C
with agitation (750 rpm) without or with inhibitors and
stimuli (4-8 × 10
6 cells/ml, 500 μl per assay) as indicated
in the Figure legends. After the incubation cells were
fixed by addition of 0.5 ml 20% trichloroacetic acid
(TCA) prewarmed at 37°C and a 5 minute incubation,
or (for visualization of EGFP-tagged proteins) by incuba-
tion with 3.7% (final) paraformaldehyde (PFA) for 10
minutes at 37°C. In part of the experiments, cells resus-
pended in Gey’s buffer containing calcium and magne-
sium were plated on glass coverslips coated with 20 μg/
ml fibronectin, followed by incubation without or with
inhibitors and stimuli, and TCA fixation. Cells then
were washed with PBS, cytocentrifuged, permeabilized
with lysolecithin (60 μg/ml) for 10 minutes at RT and
washed with PBS. Cells were then blocked for 30 min-
utes with blocking buffer (PBS containing 5% BSA and
10% normal goat serum). Subsequently cells were incu-
bated with the primary antibody diluted in PBS, 0.5%
BSA at room temperature for one hour (dilutions: rabbit
anti-flotillin-2, murine anti-flotillin-1, rabbit anti-CD3,
all diluted 1:100; murine anti-flotillin-2, rabbit anti-P-
ERM, murine anti- human PSGL-1, murine anti-actin:
all diluted 1:400; rabbit or murine anti-HA-antibody:
diluted 1:500). The preparations were then rinsed once
with TBST (50 mM Tris, pH 7.4, 150 mM NaCl, 0.05%
Tween) and twice with PBS and blocked again for 15
minutes with blocking buffer. Cells were then incubated
w i t ht h ea p p r o p r i a t es e c o n d a r ya n t i b o d i e s( A l e x a4 8 8 -
conjugated goat-anti-rabbit or goat anti-mouse IgG anti-
bodies diluted 1:500) at room temperature for 1 hour,
followed by washing once with TBST and twice with
PBS. Images were taken with a confocal laser scanning
microscope Olympus Fluoview FV1000-IX81, 63× oil
immersion objective. Flotillin-enriched aggregates
located at the plasma membrane of at least 1 μmo rl a r -
ger (maximally approximately 4 μm) were defined as
“caps”.
Constructs
Constructs encoding for flotillin-2 or flotillin-1 C-term-
inally tagged with EGFP and flotillin-2 or flotillin-1 C-
terminally tagged with mCherry were prepared as
described [16].
Flotillin-1 or -2 cloned into the plasmid pEGFP-N1
[16] were used as a PCR template to generate the
mutants flotillin-1-C34A and flotillin-2-G2A. The sin-
gle-point mutations were inserted by PCR using specific
primers, and the products were cloned into the vectors
pEGFP-N1 or pmCherry-N1 (ClonTech Laboratories).
The deletion mutant flotillin-2-R1MCT [18] was
obtained by PCR using flotillin-2 cloned into pEGFP-N1
as template and primers introducing a HindIII restric-
tion site instead of the SPFH domain (aa 30-184). The
fragments were then subcloned into the vector pEGFP-
N1.
For preparation of constructs encoding for HA-tagged
proteins, the plasmids described above containing flotil-
lin-1, flotillin-2, flotillin-1-C34A and flotillin-2-G2A
were used as a PCR template. Then the PCR products
were cloned into the phCMV3 Vector (Genlantis), gen-
erating constructs encoding flotillins C-terminally tagged
with HA.
Transient transfections of T-lymphocytes
For transfections, 5-8 × 10
6 T-lymphoblasts or freshly
isolated T-lymphocytes were resuspended in 100 μl
human T cell nucleofector solution (Amaxa, Köln, Ger-
many) diluted 1:2 with PBS and 2-3 μg of plasmid DNA
were added. Then, the cell suspension and the plasmid
DNA were transferred to a cuvette and Nucleofection
was carried out (Amaxa Nucleofector, program T-23 for
T-lymphoblasts, program U-14 for freshly isolated T-
lymphocytes). Immediately, 500 μl of medium with 20%
FCS was added and the cells were transferred to a pre-
warmed 12-well plate containing 2.5 ml of medium with
20% FCS, followed by incubation at 37°C in a CO2 incu-
bator for 4 hours. Transfected cells were then washed
and resuspended in Gey’s solution, followed by stimula-
tion with SDF-1 (40 ng/ml) for 15 minutes at 37°C, cell
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experiments, T-lymphoblasts were incubated for 24
hours in the absence of IL-2 at 37°C prior to transfec-
tions. Five hours after transfection, IL-2 was added to
the medium. 22 hours after transfection, cells were incu-
bated with SDF-1 (40 ng/ml) in Gey’s medium lacking
calcium and magnesium for 15 min, followed by fixation
and staining.
Fluorescence recovery after photobleaching (FRAP)
experiments
T-lymphocytes were transfected with either flotillin-2-
EGFP alone or with flotillin-2-EGFP and flotillin-1-
mCherry together, followed by an incubation for 4
hours at 37°C in a CO2 incubator and a 15 minutes
incubation in the absence or presence of 40 ng/ml SDF-
1i nG e y ’s medium with 5% BSA. An aliquot of 5 μlo f
cell suspension (10 × 10
6 cells/ml) was then immediately
placed on a glass slide, covered with a glass coverslip
and sealed with hot paraffin. Live-cell confocal imaging
was performed at room temperature with a confocal
laser scanning microscope Olympus Fluoview FV1000-
IX81, 63× oil immersion objective. A picture of the cells
was taken 2 seconds before bleaching of the EGFP or
mCherry moiety. A circular region of interest (ROI) of
2.5 μm in diameter was continuously bleached at 8% of
full laser power (473 nm for EGFP; 559 nm for
mCherry) for 12 seconds. Seven seconds after the com-
pletion of bleaching the first frame was taken. Fluores-
cence recovery was observed for 140 seconds (20
frames) at 0.5-1% laser power. For analysis the fluores-
cence of the bleached ROIs, corrected for the reduction
in fluorescence of control ROIs located outside of the
bleached area in the same cell which occurs due to tak-
ing of frames, and normalized to the initial fluorescence
in the ROIs before bleaching, were plotted against time.
The mobile fraction was calculated after correction for
bleaching of the control ROIs according to MF =( F FR-
F0)/Fi-F0) where FFR is the average fluorescence after full
recovery, F0 is the fluorescence immediately after the
bleach and Fi is the fluorescence just before
photobleaching.
Statistics
Differences between data were analysed with the Stu-
dent’s t test, with a P value < 0.05 considered significant.
Data correspond to the mean ± s.e.m.
Results
Flotillin-1 and -2 redistribute rapidly to the uropod upon
chemotactic stimulation of human T-lymphoblasts
T-lymphoblasts were incubated for 16 hours in the
absence of IL-2 in order to reduce spontaneous activa-
tion in the absence of chemokine. Then cells were
stimulated in suspension with the chemokine SDF-1 to
induce polarization and migration. Before activation
with SDF-1, T-lymphoblasts were mostly spherical with
some polarized cells (18 ± 3%, n = 7, average number of
total cells assessed per experiment: 70). 15 minutes after
addition of the chemokine, 61 ± 4% (n = 7; a total of 58
cells assessed per experiment) of the T-lymphoblasts
were fully polarized, featuring a protruding F-actin-rich
leading edge and a contracted uropod (Figures 1A-C;
2A-C). We analyzed reorganization of the raft scaffold-
ing proteins flotillin-1 and -2 during cell activation, in
comparison with that of the uropod-associated proteins
PSGL-1 and activated, phosphorylated ERM proteins.
In the majority of the T-lymphoblasts incubated in the
absence of chemokine, flotillin-1 and -2 were located in
small randomly distributed plasma membrane-associated
patches (Figure 1A-C, left panels). In 22 ± 3% (n = 6; 61
cells assessed per experiment) of cells preformed large
caps of flotillin-2 of approximately 2 to 4 μmw e r e
detectable. Comparable data were obtained for flotillin-
1: in 21 ± 6% (n = 3) of 51 cells assessed per experiment
this protein was capped. PSGL-1 showed mainly a punc-
tate random location, with little overlap with flotillin-2
(Figure 1A). Activated ERM proteins phosphorylated on
the C-terminal threonine (P-ERM) also showed enrich-
ment in small patches randomly distributed at the
plasma membrane rarely overlapping with flotillin-1
(Figure 1B).
Upon stimulation with SDF-1 for 1 minute, the per-
centage of cells with large caps enriched in colocalizing
flotillin-1 and -2 increased markedly (Figure 1C). PSGL-
1 colocalized with flotillin caps in 75 ± 4% (n = 3; 68
cells inspected per experiment) of cells with flotillin
caps (Figure 1A, middle panels), well comparable to our
findings with human neutrophils [16]. P-ERM staining
was decreased in part of the cells, but in 51 ± 4% (n =
3; 43 cells inspected per experiment) of the cells with
flotillin-2 caps, P-ERM cocapped with flotillin (Figure
1B, middle panels); somewhat in contrast to our findings
with human neutrophils where capping of P-ERM lags
behind that of flotillins [16]. The flotillin caps always
were located in areas opposite to ruffles (Figure 1A-C,
middle panels). After 15 minutes of stimulation with
SDF-1, flotillin-2 capped in the uropod of 64 ± 6% (n =
5, 58 cells assessed per experiment) of the cells, coloca-
lizing with flotillin-1 (Figure 1C) and also with PSGL-1
and P-ERM (Figure 1A,B, right panels). The fraction of
cells with flotillin-2 caps in probes stimulated with SDF-
1 for 15 minutes was significantly increased relative to
unstimulated controls (3.2 ± 0.3-fold, n = 5, P < 0.025)
(immunofluorescence pictures: Figure 1A-C, Figure 2A,
B; quantitative evaluation: Figure 2D). Flotillin caps were
always localized opposite to F-actin-rich ruffles located
in the front (Figure 2B). Fifteen minutes after addition
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Page 4 of 17Figure 1 Redistribution of flotillin-1 and -2, PSGL-1 and P-ERM upon stimulation of human T-lymphoblasts in suspension. (A-C) After an
overnight incubation in the absence of IL-2, cells were incubated either for 45 min at 37°C (control) or were stimulated with 40 ng/ml SDF-1 for
1 or 15 minutes after a 44 or 30 minutes preincubation at 37°C (total incubation time 45 minutes). Cells were then fixed with 10% TCA and
double-labeled for flotillin-2 (flo2; rabbit Ab) and PSGL-1 (murine Ab) in (A) or for flotillin-1 (flo1; murine Ab) and P-ERM (rabbit Ab) in (B). or for
flotillin-1 (murine Ab) and flotillin-2 (rabbit Ab) in (C). Asterisks indicate cells shown enlarged in the panels labelled “detail”. Dic; differential
interference contrast. Bar, 10 μm. Note that in panels C overlays only are shown.
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Page 5 of 17Figure 2 Role of the cytoskeleton in flotillin- 2 and PSGL-1 capping in human T-lymphoblasts in suspension. (A,B) After an overnight
incubation in the absence of IL-2, T-lymphoblasts were incubated for 45 minutes at 37°C (control) or were preincubated for 30 minutes without
or with latrunculin A (lat; 1 μM) or jasplakinolide (jasp; 5 μM) or blebbistatin (ble; 100 μM) or Y-27632 (Y; 10 μM) respectively followed by
stimulation with 40 ng/ml of SDF-1 for 15 minutes at 37°C. Cells were then fixed with 10% TCA and (A) double-labeled either for flotillin-2 (flo2;
rabbit Ab) and PSGL-1 (murine Ab) or (B) for flotillin-2 (flo2, rabbit Ab) and actin (murine Ab). Bar, 10 μm. (C-E) T-lymphoblasts were treated as
described in (A) followed by evaluation of the % of polarized cells with contracted uropods (C); or evaluation of the % of cells with flotillin-2
caps (D) or evaluation of the % of cells with PSGL-1 caps (E). Mean ± s.e.m. of 3-7 independent experiments. At least 40 cells per sample and
experiment were analyzed.
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Page 6 of 17of SDF-1, flotillin-1 colocalized with flotillin-2 in 96 ±
5% (n = 3, 57 cells inspected per experiment) of the
cells with flotillin uropod caps (values for PSGL-1: 75 ±
11%, n = 4, 58 cells inspected per experiment; P-ERM:
56 ± 6%, n = 4, 50 cells inspected per experiment) (Fig-
ure 1A,B). P-ERM staining showed some variation in
individual cells, very likely due to variations in the bal-
ance of protein kinase and phosphatase activity, as
observed also for migrating human neutrophils [19].
Chemokine stimulation of T-lymphocytes thus induces a
rapid and marked reorganization and capping of flotil-
lins coinciding with capping of other uropod located
proteins. Comparable data were obtained with freshly
isolated T-lymphocytes (data not shown).
When plated on fibronectin-coated glass in the
absence of SDF-1, a much higher percentage of cells
showed polarization and flotillin capping in the uropods
as compared to cells in suspension, indicating that acti-
vation mediated by integrin engagement also induces
flotillin uropod recruitment. Incubation with SDF-1 of
cells plated on fibronectin induced only a small, statisti-
cally not significant increase in the fraction of polarized
cells and did not further increase the fraction of cells
with flotillin caps (Figure 3A-C).
Flotillin capping requires the integrity of the actin
cytoskeleton but not Rho-kinase and myosin II activity in
chemokine-stimulated T lymphoblasts
The actin cytoskeleton has been implicated in contribut-
ing to the cellular localization of flotillins [16,18].
Indeed, disruption of the actin cytoskeleton with latrun-
culin A treatment almost completely suppressed polari-
zation and formation of the SDF-1-induced flotillin-2
and PSGL-1 caps in resting and stimulated T-lympho-
blasts in suspension (Figure 2). Cells assumed instead a
spherical morphology with a smooth surface. Jasplakino-
lide, which inhibits depolymerisation of actin filaments
and enhances enrichment of F-actin in the cortical
cytoskeleton [20], similarly suppressed cell polarization
and capping of flotillin-2 and PSGL-1 in resting and sti-
mulated cells (immunofluorescence pictures: Figure 2A,
B; quantitative evaluation: Figure 2C-E). These data
show that dynamic actin turnover is required for cap-
ping of these proteins. Comparable data were obtained
for flotillin-1 in T-lymphoblasts and for flotillin-1 and
-2 in freshly isolated T-lymphocytes (not shown). We
could not study the impact of disruption of actin fila-
ments on cells plated on fibronectin, as cell adhesion
was almost completely inhibited by treatment of cells
with latrunculin or jasplakinolide (not shown).
Myosin II has been implicated in uropod formation of
T-lymphocytes [4]. In agreement with these findings,
inhibition of Rho-kinase by Y-27632 or of myosin II
activity by blebbistatin almost completely abolished
formation of a contracted tail in T-lymphoblasts stimu-
lated by SDF-1 in suspension after inhibitor treatment.
The treated cells assumed a spherical morphology with
small ruffles on one side. However capping of flotillins
and PSGL-1 in SDF-1-stimulated cells was not signifi-
cantly reduced by pretreatment with Y-27632 or blebbis-
tatin (immunofluorescence pictures: Figure 2A,B;
quantitative evaluation: Figure 2C-E). The flotillin- and
PSGL-1-rich caps in cells treated with Y-27632 or bleb-
bistatin were always located opposite to F-actin-rich ruf-
fles, on the smooth side of the cells presumably at the
site of the former uropod (Figure 2B). Comparable data
were obtained for flotillin-1 in T-lymphoblasts, and for
flotillin-1 and -2 in freshly isolated T-lymphocytes (not
shown).
Similarly, flotillin caps of cells plated on fibronectin
were not abolished by pretreatment with blebbistatin or
Y-27632 (Figure 3A-C). The effects of these inhibitors
on flotillin capping were mostly not statistically signifi-
cant with the exception of the effect of Y-27632 on cells
plated on fibronection in the absence of SDF-1 (inhibi-
tion: 48 ± 11%, n = 4, P < 0.025). In contrast, pretreat-
ment with Y-27632 or blebbistatin, without or with
SDF-1, significantly reduced the fraction of polarized
cells (Figure 3B). Cells treated with these inhibitors were
more spread (Figure 3A) in agreement with previous
findings [21]. Some of the cells exhibited long extended
tails, indicating problems with tail retraction (not
shown). In conclusion, actin-dependent stimulus-
induced coalescence of flotillin- and PSGL-1-containing
microdomains in T cells does not require Rho-kinase
and myosin II activity.
Mechanisms of flotillin capping in T lymphoblasts: roles
of fatty acid modifications and the putative actin binding
site in flotillin-2
We used expression of C-terminally tagged wild type
and mutated flotillins to explore mechanisms involved
in uropod capping. Wild type flotillins singly expressed
in chemokine-stimulated T lymphoblasts showed a uni-
form membrane association and were also present in
intracellular structures located in the uropod of stimu-
lated T lymphoblasts (Figure 4A, upper panels). This is
different from location of the endogenous flotillins
which are capped in the uropod (Figure 1, 2). Possibly,
uropod capping of flotillins depends on heterooligomer
formation, and there may not be enough endogenous
uncomplexed flotillins available for heterooligomer for-
mation between tagged singly expressed flotillins and
endogenous flotillins. According to Solis et al. [22]
homooligomerization of singly expressed tagged flotillins
is favoured over heterooligomerization with endogenous
flotillins. Indeed, in support of a requirement for hetero-
oligomerization of uropod capping, coexpressed tagged
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Page 7 of 17Figure 3 Roles of myosin II and Rho-kinase in flotillin capping in human T-lymphoblasts adhering to fibronectin. A: After an overnight
incubation in the absence of IL-2, T-lymphoblasts (1.5 × 10
6cells per well) were placed on fibronectin-coated glass coverslips without or with
blebbistatin (ble; 100 μM) or Y-27632 (Y; 10 μM) respectively and allowed to adhere for 30 minutes at 37°C. To part of the samples, 40 ng/ml of
SDF-1 was added followed by a further 30 minutes incubation at 37°C (total incubation 60 minutes). Cells were then fixed with 10% TCA and
double-labeled for flotillin-2 (flo2; rabbit Ab) and flo1 (murine Ab). Bar, 10 μm. Asterisks indicate cells shown enlarged in the panels labelled
“detail”. B, C: T-lymphoblasts were treated as described in (A) followed by evaluation of the % of polarized cells with contracted uropods (B); or
evaluation of the % of cells with flotillin-2 caps (C). Mean ± s.e.m. of 3-4 independent experiments. At least 40 cells per sample and experiment
were analyzed. *P < 0.025, **P < 0.0125, ***P < 0.0005 for differences between data obtained for cells incubated in the absence and presence of
inhibitors.
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Page 8 of 17Figure 4 Roles of flotillin-membrane/raft association in flotillin cap formation in human T-lymphoblasts. (A) Cells were transfected singly
(upper panels) or together (lower panels) with 3 μg of constructs encoding for wild type tagged flotillins (flo1-HA; flo2-EGFP). (B) Cells were
transfected singly (upper panels) with constructs encoding for tagged flotillins mutated in residues which carry covalently linked fatty acids (flo1-
C34A-HA or flo2-G2A-EGFP), or together with flo2-EGFP and flo1-C34A-HA (middle panel) or together with flo1-HA and flo2-G2A (lower panel).
(A,B) 4 hr after transfection cells were stimulated with 40 ng/ml SDF-1, fixed with PFA and the HA-tag was visualized by immunofluorescence
staining. Numbers in the panels indicate the fraction of cells with flotillin caps (mean ± s.e.m.) obtained in 3-5 independent experiments.
Comparable data were obtained when using mcherry-flotillin-1 instead of HA-tagged flotillin-1 (data not shown). Bar, 10 μm.
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Page 9 of 17flotillin-1 and -2 colocalized in the uropod of 82 ± 6% of
the transfected T cells, comparable to the location of the
endogenous proteins. Both proteins were almost exclu-
sively restricted to the uropod. (Figure 4A, lower
panels).
I no r d e rt oe x p l o r et h er o l eo f membrane/raft associa-
tion of flotillins in uropod targeting, we introduced point
mutations (G2A in flotillin-2 and C34A in flotillin-1) that
have been reported to abolish fatty acid modifications
and plasma membrane associations of flotillins [23,24].
Both proteins mutated in this respect, that is, flotillin-2-
G2A and flotillin-1-C34A, indeed showed, when trans-
fected singly (Figure 4B, upper panels) or together (not
shown), a diffuse cytosolic location, in agreement with
previous findings on these mutants in other cell types,
indicating a loss of plasma membrane association [23,24].
Interestingly when wild-type flotillin-2 and flotillin-1-
C34A were co-transfected, uropod capping of both pro-
teins was as efficient as that of wild-type proteins (Figure
4B, middle panels). In contrast, when flotillin-2-G2A and
wild-type flotillin-1 were co-transfected, almost no cap
formation occurred (Figure 4B, lower panels). In sum-
mary the data shown in Figure 4 strongly suggest that
heterooligomerization of flotillin-1 and -2 is required for
uropod capping and that membrane association of flotil-
lin-2, but not of flotillin-1, is necessary for targeting of
the heterooligomers to the uropod.
We further analyzed the role of the F-actin binding
site located in the N-terminal half of flotillin-2. A dele-
tion construct lacking amino acids 31-183 of flotillin-2
(R1MCT) still retains the ability to interact with mem-
branes and with flotillin-1 but does not colocalize any-
more with F-actin when expressed in cells [18]. This
singly expressed deletion construct showed a uniform
membrane association and was also present in vesicles
(Figure 5, upper left panels). When coexpressed with
wild type flotillin-1, this location was not changed, little
capping was observed and both proteins colocalized,
suggesting that direct F-actin interaction is indeed
required for flotillin uropod capping in T-lymphocytes
(Figure 5, lower panels).
Stability of flotillin caps in T-lymphoblasts
We wanted to compare lateral mobility of singly trans-
fected membrane-associated flotillin-2-EGFP with that
of flotillin-2-EGFP co-assembled with flotillin-1-
mCherry in large caps. We therefore carried out FRAP
(fluorescence recovery after photobleaching) in trans-
fected T-lymphoblasts stimulated with SDF-1. Note that
these FRAP experiments were carried out at 20°C as
rapid shape changes and migration occurring at 37°C
precluded accurate bleaching, acquisition and evaluation
of FRAP data. At 20°C cells were not any more polar-
ized but the flotillin caps persisted for a longer time.
FRAP experiments demonstrated a relatively high mobi-
lity of singly transfected flotillin-2-EGFP at the plasma
membrane. The flotillin-2-EGFP fluorescence recovered
with a half time of approximately 30 seconds and the
mobile fraction MF corresponded to 0.80 ± 0.06 (a total
of 7 cells analyzed from 3 independent experiments)
(Table 1). Comparable data were obtained for cells
transfected with flotillin-1-EGFP (Table 1). In contrast,
in caps consisting of flotillin-1-mCherry and flotillin-2-
EGFP, almost no recovery of fluorescence within the
time of observation was observed. A mobile fraction of
only MF = 0.06 ± 0.02 (7 cells; 3 independent experi-
ments) (Table 1) suggests nearly complete immobiliza-
tion of flotillin-2 in the caps. Comparable data were
obtained for flotillin-1-EGFP cotransfected with flotillin-
2-mCherry (Table 1). We now investigated the impact
of chemokine stimulation on the lateral mobility of flo-
tillins. To this end we used transfected freshly isolated
T-lymphocytes, as the basal level of flotillin cap forma-
tion in these cells in the absence of chemokine is lower
as compared to T-lymphoblasts. As shown in Figure 6
and Table 1, flotillin-2-EGFP transfected alone is very
mobile irrespective of the presence of chemokine. How-
ever, in cells expressing both flotillin isoforms, mobility
of flotillin-2-EGFP was markedly decreased by 53 ± 7%
(n = 4, P < 0.01) already in the absence of chemokine as
compared to singly transfected cells (Table 1). Chemo-
kine addition resulted in almost complete immobiliza-
tion of flotillin-2-EGFP when co-expressed with flotillin-
1 (69 ± 7% reduction of MF (n = 4, P < 0.005), as com-
pared to cells coexpressing both flotillins and incubated
in the absence of chemokine) (Table 1). Our results
strongly suggest that the lateral mobility of flotillins is
regulated a) by heterooligomer formation and b) by che-
mokine stimulation.
In a separate series of experiments we studied the role
of F-actin in immobilizing flotillins in freshly isolated T-
lymphocytes. As shown in Table 2, pretreatment of cells
with latrunculin A markedly and significantly increased
the lateral mobility of co-expressed flotillins in cells
exposed to SDF-1 6.3 ± 1.4-fold (n = 3, P < 0.001),
whereas the impact of this treatment on flotillin mobi-
lity in cells not stimulated by chemokine was smaller
(2.1 ± 0.5-fold; n = 3, P < 0.05). In agreement with the
results obtained with latrunculin on cells transfected
with wild type flotillins, the flotillin-2 mutant R1MCT
lacking the F-actin binding site showed a mobility com-
parable to that of singly transfected wild type flotillins
irrespective of the presence of co-expressed wild type
flotillin-1 and SDF-1 (Table 3).
These findings suggest that SDF-1 markedly enhances
anchoring of flotillin-rich membrane microdomains to
the underlying F-actin network which results in almost
complete immobilization of these proteins.
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lating flotillin mobility using FRAP of blebbistatin-trea-
ted cells. In this case bleaching of EGFP could not be
used, as illumination of cells incubated with blebbistatin
at 450-490 nm (but not at 510-560 nm) has been shown
to cause dose-dependent inhibition of cell motility and
cell death due to generation of toxic blebbistatin pro-
ducts [25]. We therefore used bleaching of mCherry-
tagged flotillins at 559 nm for these experiments. As
shown in Table 4, blebbistatin treatment did not signifi-
cantly affect flotillin-2 mobility, irrespective of the pre-
s e n c eo fS D F - 1 .C o m p a r a b l ed a t aw e r eo b t a i n e df o r
flotillin-1 tagged with mCherry (data not shown). Myo-
sin II thus appears not to be involved in immobilization
of flotillin-rich membrane microdomains.
Transfection of T-lymphoblasts with flotillin-G2A-HA
impairs cell polarization and capping of endogenous
flotillin-1 and PSGL-1
In order to unravel the role of flotillins in T-lymphocyte
migration and polarization we attempted to down-regu-
late flotillin expression using nucleofection with siRNA
in T-lymphoblasts. However we only achieved maximally
50% downregulation of flotillin-2 and -1. Uropod forma-
tion was not significantly impaired (data not shown) sug-
gesting that the residual flotillin proteins are sufficient to
maintain cell polarization. We therefore tested the
impact of transiently overexpressing flotillin-2-G2A in T-
lymphoblasts, as compared to wild type flotillin-2, on
Figure 5 Role of flotillin-F-actin interaction in flotillin cap formation in human T-lymphoblasts. Cells were transfected singly (upper
panels) or together (lower panels) with a construct encoding for flotillin-2 lacking the F-actin binding domain (R1MCT-EGFP) and flo1-HA, as
indicated. 4 hr after transfection cells were stimulated with 40 ng/ml SDF-1, fixed with PFA and the HA-tag was visualized by
immunofluorescence staining using a murine monoclonal anti-HA antibody. Numbers in the panels indicate the fraction of cells with flotillin
caps (mean ± s.e.m.) obtained in 3-4 independent experiments.
Table 1 FRAP analysis of the lateral mobility of flotillins
in T-lymphocytes
Transfection Cell type MF - SDF-1
(n)
MF + SDF-1
(n)
flo1-EGFP T-lymphoblast n.d. 0.88 ± 0.05
(12)
flo1-EGFP/flo2-
mCherry
T-lymphoblast n.d. 0.04 ± 0.01
(10)
flo2-EGFP T-lymphoblast n.d. 0.80 ± 0.06
(7)
flo2-EGFP/flo1-
mCherry
T-lymphoblast n.d. 0.06 ± 0.02
(7)
flo2-EGFP Freshly isolated T-
cells
0.79 ± 0.04
(14)
0.71 ± 0.03
(15)
flo2-EGFP/flo1-
mCherry
Freshly isolated T-
cells
0.38 ± 0.04
(16)
0.11 ± 0.02
(11)
FRAP analysis involving local bleaching of EGFP was carried out as described
in the legend of Figure 6 with cells preincubated in the absence or presence
of SDF-1, as indicated. The mobile fraction (MF) was calculated for each
individual cell and then averaged from a total of n = 7-16 cells, as indicated
(mean ± s.e.m.) (data obtained in 2-4 independent experiments). N.d. = not
done.
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Page 11 of 17Figure 6 FRAP analysis of the lateral mobility of flotillin-2-EGFP, expressed without or with flotillin-1-mCherry in T-lymphocytes.
Freshly isolated human T-lymphocytes were transfected with either flotillin-2-EGFP alone (A,B,E,F) or with flotillin-2-EGFP and flotillin-1-mCherry
together (C,D,G,H), followed by a 4 hour incubation prior to FRAP analysis. Just before the FRAP analysis, cells were incubated for 15 minutes in
the absence (left panels) or presence (right panels) of 40 ng/ml SDF-1, followed by bleaching of EGFP using excitation at 473 nm for all samples.
Images of representative cells 2 seconds before (pre) and 7- 133 seconds after (post) completion of bleaching are shown, as indicated. Bleached
regions of interest (ROI) are shown as red circles. Bar, 10 μm. (E-H) Fluorescence recovery time course after photobleaching of EGFP (mean ± s.e.
m.) averaged from 11-16 cells derived from 3-4 independent experiments, as indicated in the panels. The prebleaching intensity was set to 100
in panels E-H. The values were corrected for bleaching due to acquisition of frames assessed in control ROIs corresponding to non-bleached
regions analyzed in the same cells where localized bleaching was performed (not shown in A-D). Note that these FRAP experiments were carried
out at 20°C, where cells are not any more polarized but still feature flotillin caps. At 37°C rapid shape changes and migration precluded accurate
bleaching, acquisition and evaluation of FRAP data.
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and the uropod-associated protein PSGL-1. Flotillin-2-
G2A has been suggested to act as a dominant-negative
mutant in HeLa cells [26]. It may act by forming unpro-
ductive complexes with endogenous flotillin-1, thus pre-
venting flotillin-1 in forming functional heterooligomers
with endogenous flotillin-2. This could lead to displace-
ment of endogenous flotillins from the uropod and
impaired cell polarization. In order to reduce as much as
possible endogenous stable flotillin caps, cells were prein-
cubated in buffer lacking IL-2 prior to transfections. We
first wanted to know whether overexpression of flotillin-
2-G2A indeed displaces endogenous flotillin-1 from the
uropod. Whereas the majority of cells overexpressing
wild-type flotillin-2 showed clear-cut uropod-located flo-
tillin-1 caps, we observed a statistically significant 57 ±
13% (n = 4; P < 0.0125) reduction of flotillin-1 caps in
cells expressing mutant flotillin-2 (immunofluorescence
pictures: Figure 7A; quantitative evaluation: Figure 7D).
Similarly, capping of PSGL-1 was significantly reduced in
cells expressing the flotillin-2 G2A mutant by 53 ± 11%
(n = 3; P < 0.025) (immunofluorescence picture: Figure
7B; quantitative evaluation: Figure 7D). Importantly, cell
polarization, that is, cell elongation and front-tail polarity
with a clearly defined uropod was also markedly reduced
in cells expressing mutant flotillin-2, by 66 ± 15% (n = 3;
P < 0.025) (Figure 7A-C), supporting indeed a role of flo-
tillins in T-lymphocyte polarization, similar to recently
published work on neutrophils [17].
Discussion
Flotillin-1 and -2 have previously shown to be enriched
in membrane-associated caps in Jurkat T-cells and
Molt4 cells and in the uropods of polarized human T-
lymphoblasts, monocytes,C D 3 4 - p o s i t i v ec e l l sa n d
human neutrophils [12-14,16]. This polarized location of
flotillins appears to be restricted to hematopoietic cells
as it does not occur in for example polarized epithelial
cells [14]. In murine neutrophils, flotillins have recently
been shown to be required for uropod formation and
migration through matrigel [17]. We have now investi-
gated mechanisms and functional role of flotillin cap-
ping in human T-lymphoblasts.
Stimulus-dependent flotillin capping in T-lymhocytes
We show that preformed large flotillin caps of 2-4 μm
are present in 22 ± 3% (n = 6) of human primary T
lymphoblasts incubated in suspension prior to activation
with chemokine, and that the number of such caps is
markedly and rapidly increased within one minute upon
chemotactic stimulation of cells in suspension. We
further show that flotillin-1 and -2 are localized almost
exclusively in caps at the tip of the uropod in the rear
of polarized cells, partially colocalizing with other uro-
pod resident molecules such as P-ERM and PSGL-1. Sti-
mulus-dependent coalescence of flotillin-containing
microdomains is thus an early event during T cell acti-
vation, and such domains may mark the site of the
future uropod, comparable to our previous findings with
human neutrophils [16]. Similar data were obtained for
cells plated on fibronectin, although there formation of
flotillin caps was enhanced already in the absence of
SDF-1, presumably by integrin-mediated cell activation.
Role of the cytoskeleton in flotillin cap formation
The actin cytoskeleton is required for organization and
function of membrane microdomains and redistribution
of raft-associated proteins in the uropod of leukocytes
[27-29]. Suppression of myosin II activation by the Rho-
kinase inhibitor Y-27632 or the myosin II inhibitor bleb-
bistatin, or myosin IIA knockout inhibits chemokine-
induced uropod formation of T-lymphocytes treated in
suspension, promotes long non-retracting tails in T-cells
plated on substrate, enhances cell spreading and mark-
edly attenuates T cell migration and chemotaxis in vitro
and in vivo [21,30-34]. Moreover retrograde cortical
flow of actin filaments depending on myosin II contrac-
tility been implicated in accumulation of actin-attached
Table 2 Impact of pretreatment with latrunculin A on the lateral mobility of flotillin-2 cotransfected with flotillin-1 in
freshly isolated T-lymphocytes
Transfection Pretreatment MF - SDF-1 (n) MF + SDF-1 (n)
flo2-EGFP/flo-1-mCherry No pretreatment 0.25 ± 0.03 (11) 0.11 ± 0.04 (12)
flo2-EGFP/flo1-mCherry Preincubation for 30 min with latrunculin A (1 μM) 0.46 ± 0.07 (12) 0.66 ± 0.07 (11)
FRAP analysis involving local bleaching of EGFP was carried out as described in the legend of Figure 6 with cells preincubated in the absence or presenceo f
SDF-1, and without or with pretreatment with latrunculin A as indicated. The mobile fraction (MF) was calculated for each individual cell and then averaged from
a total of n = 11 - 12 cells observed in 3 independent experiments, as indicated (mean ± s.e.m.).
Table 3 Lateral mobility of the flotillin-2 mutant lacking
the actin binding domain (R1MCT) expressed in freshly
isolated T-lymphocytes without or with wild type
flotillin-1-mCherry
Transfection MF - SDF-1 (n) MF + SDF-1 (n)
R1MCT 0.72 ± 0.05 (15) 0.79 ± 0.06 (14)
R1MCT/flo1-mCherry 0.65 ± 0.06 (14) 0.79 ± 0.05 (15)
FRAP analysis involving local bleaching of EGFP was carried out as described
in the legend of Figure 6 with cells preincubated in the absence or presence
of SDF-1 as indicated. The mobile fraction (MF) was calculated for each
individual cell and then averaged from a total of n = 14 - 15 cells observed in
3 independent experiments, as indicated (mean ± s.e.m.).
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explored the contribution of actin and myosin II to the
capping of flotillin isoforms in the uropods of T-lym-
phoblasts. We show that this event depends on a
functional actin network, but is not abolished by inhibi-
tion of Rho-kinase or myosin II activity, suggesting that
retrograde cortical flow of F-actin mediated by myosin
II very likely is not involved. Rather, flotillins appear to
Table 4 Impact of pretreatment with blebbistatin on the lateral mobility of flotillin-2 cotransfected with flotillin-1 in
freshly isolated T-lymphocytes
Transfection Pretreatment MF - SDF-1 (n) MF + SDF-1 (n)
flo2-mCherry/flo-1-EGFP No pretreatment 0.43 ± 0.05 (11) 0.11 ± 0.03 (13)
flo2-mCherry/flo1-EGFP Preincubation for 30 min with blebbistatin (100 μM) 0.49 ± 0.06 (9) 0.09 ± 0.02 (10)
FRAP analysis involving local bleaching of mCherry was carried out as described in the legend of Figure 6 with cells preincubated in the absence or presence of
SDF-1, and without or with pretreatment with blebbistatin as indicated. The mobile fraction (MF) was calculated for each individual cell and then averaged from
a total of n = 9 - 13 cells observed in 3 independent experiments, as indicated (mean ± s.e.m.).
Figure 7 Impact of transfection of T-lymphoblasts with flotillin-2-G2A on cell polarization and capping of uropod components. (A,B) T-
lymphoblasts were incubated for 22 hours in the absence of IL-2, followed by transfection with 2 μg of constructs encoding for HA-tagged
wild-type flotillin-2 (flo2) or flotillin-2-G2A (flo2-G2A). Five hours after transfection, IL-2 was added followed by a further 17 hour incubation,
stimulation with SDF-1 (15 minutes, 40 ng/ml), TCA-fixation and double-labeling for HA-tagged wild-type or mutated flotillin-2 (flo2-HA; flo2-G2A-
HA) and endogenous flotillin-1 (flo1) (A) or HA-tagged wild-type or mutated flotillin-2 and endogenous PSGL-1 (B), using a polyclonal rabbit anti-
HA antibody and monoclonal murine antibodies directed against flotillin-1 and PSGL-1. Bar, 10 μm. (C,D) T-lymphoblasts were treated as
described for (A,B), and the amount of polarized transfected cells (n = 3) (C) or the amount of transfected cells with capped endogenous
flotillin-1 (n = 4) or PSGL-1 (n = 3) (D) were evaluated (mean ± s.e.m.). 30-50 transfected cells were analyzed per sample and experiment. *P <
0.025, **P < 0.0125 for differences between data obtained for cells transfected with HA-tagged wild type or mutated flotillin-2.
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phocytes are comparable to our data obtained in human
neutrophils [16].
Actin could organize flotillin caps indirectly via other
proteins or by direct interactions with flotillins. Indeed,
the SPFH domain (as 41-183) of flotillin-2 has been
shown to interact directly with F-actin in vitro, and flo-
tillin-2 lacking this domain (the deletion mutant
R1MCT) does not anymore colocalize with F-actin
when expressed in HeLa cell and N2a cells [18]. The
mutant R1MCT should still retain the capacity to form
heterooligomers as it contains the coiled-coil stretch
required for heterooligomerization [22]. We now show
that co-expression of R1MCT with wild type flotillin-1
does not result in cap formation, and that R1MCT is
highly mobile in the plane of the membrane irrespective
of cell stimulation and co-expression of wild type flotil-
lin-1, suggesting that direct F-actin interaction with flo-
tillin-2 is required for targeting the heterooligomers to
the uropod and stabilization in the uropod (Figure 5).
As rather a large part of the protein (amino acid resi-
dues 30-184; 36%) was deleted, it cannot be excluded
that the abolishment of uropod recruitment is due to a
loss of interactions with proteins other than F-actin. It
is unclear why a direct interaction with F-actin results
in flotillin raft coalescence selectively in the relatively F-
actin-poor uropod and not also in F-actin-rich ruffles at
the leading edge. A possibilit yc o u l db eas p e c i f i ci n t e r -
action with a stable F-actin population which has been
shown to be enriched in the uropod of polarized neutro-
phil-like HL-60 cells and zebrafish neutrophils, as
opposed to a dynamic F-actin pool present in the front
[35,36]. Future studies should show, if such a stable F-
actin population is also present in the uropod of polar-
ized T-lymphocytes and if it colocalizes with flotillins.
Heterooligomer formation and capping of flotillins
According to previous data, EGFP-tagged flotillin-2 sin-
gly expressed in Jurkat T-cells forms stable large caps
[12,13]. However this is not the case in naïve T-cells
and human T-lymphoblasts where we observed uniform
membrane association of singly expressed EGFP-flotil-
lin-2. The same was observed for singly expressed HA-
tagged flotillin-1 (Figure 4A, 7A). In contrast co-
expressed flotillin-1 and -2 formed stable membrane-
associated caps in almost all chemokine-stimulated,
transfected cells (Figures 4A, 6D). These data suggest,
that heterooligomer formation is required for uropod
targeting of flotillins in T cells and that singly expressed
flotillins do not heterodimerize extensively with endo-
genous flotillins. Indeed Solis et al. [22] observed that,
when expressed in neuro2a cells, homooligomerization
of singly expressed tagged flotillins is favoured over het-
erooligomerization with endogenous flotillins. They
explain this with faster de novo synthesis of the tagged
proteins. An explanation for the differences in data
o b t a i n e di nJ u r k a tc e l l sa n dT -cells could be that there
is more free endogenous flotillin-1 available for heteroo-
ligomer formation with exogenous flotillin-2 in Jurkat
cells as compared to T cells. Alternatively, complex for-
mation of flotillin-1 and -2 is required for capping only
in human peripheral blood T-cells but not in Jurkat
cells. Our data agree with the recent work of Ludwig et
al. [17] where it could be shown that flotillin-rich
microdomains are absent in mice lacking flotillin-1.
Role of covalent fatty acid modifications of flotillin-1 and
-2 in formation of uropod-associated flotillin caps
Fatty acid modifications on cysteine 34 in flotillin-1 and
glycine 2 in flotillin-2 have been shown to be required
for membrane association of flotillin-1 and -2 in other
cell types [23,24]. We now show that fatty acid modifi-
cation of flotillin-2, but not of flotillin-1 is required for
uropod targeting in T-lymphocytes using point muta-
tions of these amino acids to alanine. Wild-type mem-
brane-associated flotillin-2 can thus recruit cytosolic
flotillin-1-C34A to the uropod, whereas wild-type flotil-
lin-1 cannot recruit flotillin-2-G2A. These novel findings
suggest that membrane association of flotillin-2 is suffi-
cient and necessary for raft/membrane localization of
the heterooligomers.
In summary, our data strongly suggest that heterooli-
gomer formation and plasma membrane association of
flotillin-2 are prerequisites for uropod recruitment of
flotillins in T lymphocytes. Possibly heterooligomer for-
mation induces a conformational change in the proteins
facilitating further interactions with other binding
partners.
Lateral mobility of membrane-associated flotillins
We analyzed the lateral mobility of tagged flotillins
expressed in T-lymphocytes using FRAP. Our data show
that singly transfected flotillins are highly mobile and
show a uniform plasma membrane association irrespec-
tive of the presence or absence of chemokine. When
coexpressed, the mobility of flotillins is markedly
reduced even in the absence of chemokine. In the pre-
sence of chemokine, tagged coexpressed flotillins coa-
lesce in large uropod-located caps. Flotillins in these
large caps are almost completely immobilized (Figure 6,
Table 1). Mobility of flotillins in especially chemokine-
treated cells was markedly enhanced by latrunculin-
mediated disruption of F-actin, almost to levels of singly
transfected molecules. The impact of F-actin disruption
on flotillin mobility was much smaller (but still signifi-
cant) in cells not exposed to chemokine. Myosin II inhi-
bition did not affect flotillin mobility in resting and
stimulated cells. We propose based on these data, that
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form small randomly distributed microdomains. These
microdomains are partially immobilized by interaction
with either a subpopulation of F-actin relatively insensi-
tive to latrunculin or with unknown cellular compo-
nents. Our data support the notion that complete
immobilization of flotillins in the large, stimulus-depen-
dent caps occurs due to stimulus-dependent enhance-
ment of actin polymerization and interaction of the
flotillin rafts with a pool of stable F-actin (see above),
independent of myosin II activity.
Functional roles of flotillin caps in T-lymphocytes
We propose that flotillins act as scaffolding proteins struc-
turing the uropod and regulating signaling molecules.
Indeed our data using overexpression of the flotillin-2-
G2A mutant suggest an important role in uropod forma-
tion and recruitment of PSGL-1 (Figure 7), correlating well
with data recently published on murine neutrophils [17].
Early during lymphocyte activation, prior to uropod forma-
tion, flotillins may mark that part of the plasma membrane
that will later on, based on myosin II contractility, develop
into a uropod. These flotillin caps, stably linked to F-actin,
may prevent protrusion formation in that area and recruit
other uropod-located proteins, possibly enhancing local
rear signaling and myosin II activation [17,37]. Moreover
flotillins have been implicated in clathrin-independent
endocytosis of GPI-anchored proteins [38,39]. T cells have
been shown to contain large clathrin-based endocytic plat-
forms at the uropod which have been implicated to contri-
bute to chemotaxis [34] Similarly flotillins could be
involved in clathrin-independent endocytosis of specific
molecules involved in polarization and chemotaxis.
Conclusions
In conclusion, we provide novel evidence demonstrating
that formation of large stable uropod-associated flotillin
caps in T-lymphocyte is markedly enhanced by cell sti-
mulation. We show, that these events depend on actin
dynamics but not on actomyosin contractility. Uropod
capping of flotillins moreover requires coexpression of
flotillin-1 and -2, and thus very likely flotillin heterooli-
gomer formation, as well as the presence of a domain in
flotillin-2 implicated in direct F-actin interactions and
plasma membrane association of flotillin-2, but not -1.
We show that the lateral mobility of flotillins in the
plasma membrane is reduced by co-expression of both
flotillins and is further almost abolished by cell stimula-
tion, depending on a functional actin network. Overex-
pression of mutant flotillin-2GA unable to interact with
rafts reduces capping of endogenous flotillin-1 and
PSGL-1 and impairs chemokine induced cell polariza-
tion. Our findings suggest an important functional role
of flotillins in uropod structuring. Open questions
concern possible direct interaction partners of flotillins
in the uropod of polarized lymphocytes, and the exact
molecular mechanisms involved in stimulus-dependent
flotillin activation, capping and uropod targeting.
Acknowledgements
We thank E. Sigel and J. Burkhart for helpful discussions and critical reading
of the manuscript. This work was supported by the Swiss National Science
Foundation (Grants No 3100A_103708/1 and 3100A_129655/1) and by the
Gottfried and Julia Bangerter-Rhyner Foundation (Basel, Switzerland).
The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Author details
1Dept. of Pathology, University of Bern, CH-3010 Bern, Switzerland.
2Present
address: Membrane Biology Group, Centre for Vascular Research, University
of New South Wales, Lowy Cancer Research Centre, Sydney NSW 2052,
Australia.
Authors’ contributions
SA and JH participated in the experiments with the inhibitors; SA prepared
the flotillin constructs and carried out the transfections of tagged flotillins;
SM carried out and analyzed the FRAP experiments, JR carried out initial
experiments on purification and immunofluorescence staining of T-
lymphocytes, VN conceived and designed the experiments, analyzed the
data and wrote the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 15 February 2011 Accepted: 22 June 2011
Published: 22 June 2011
References
1. Krummel MF, Macara I: Maintenance and modulation of T cell polarity.
Nat Immunol 2006, 7:1143-1149.
2. Ley K, Laudanna C, Cybulsky MI, Nourshargh S: Getting to the site of
inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol
2007, 7:678-689.
3. Friedl P, Weigelin B: Interstitial leukocyte migration and immune
function. Nat Immunol 2008, 9:960-969.
4. Sánchez-Madrid F, Serrador JM: Bringing up the rear: defining the roles of
the uropod. Nat Rev Mol Cell Biol 2009, 10:353-359.
5. Bagorda A, Parent CA: Eukaryotic chemotaxis at a glance. J Cell Sci 2008,
121:2621-2624.
6. Manes S, Viola A: Lipid rafts in lymphocyte activation and migration. Mol
Membr Biol 2006, 23:59-69.
7. Millan J, Montoya MC, Sancho D, Sanchez-Madrid F, Alonso MA: Lipid rafts
mediate biosynthetis transport to the T lymphocyte uropod subdomain
and are necessary for uropod integrity and function. Blood 2002,
99:978-984.
8. Pierini LM, Eddy RJ, Fuortes M, Seveau S, Casulo C, Maxfield FR: Membrane
lipid organization is critical for human neutrophil polarization. J Biol
Chem 2003, 278:10831-10841.
9. Niggli V, Meszaros AV, Oppliger C, Tornay S: Impact of cholesterol
depletion on shape changes, actin reorganization, and signal
transduction in neutrophil-like HL-60 cells. Exp Cell Res 2004, 296:358-368.
10. Babuke T, Tikkanen R: Dissecting the molecular function of reggie/flotillin
proteins. Eur J Cell Biol 2007, 86:525-532.
11. Stuermer CA: The reggie/flotillin connection to growth. Trends Cell Biol
2010, 20:6-13.
12. Rajendran L, Masilamani M, Solomon S, Tikkanen R, Stuermer CA, Plattner H,
Illges H: Asymmetric localization of flotillins/reggies in preassembled
platforms confers inherent polarity to hematopoietic cells. Proc Natl Acad
Sci USA 2003, 100:8241-8246.
13. Langhorst MF, Reuter A, Luxenhofer G, Boneberg EM, Legler DF, Plattner H,
Stuermer CA: Preformed reggie/flotillin caps: stable priming platforms for
macrodomain assembly in T cells. FASEB J 2006, 20:711-713.
Affentranger et al. BMC Cell Biology 2011, 12:28
http://www.biomedcentral.com/1471-2121/12/28
Page 16 of 1714. Rajendran L, Beckmann J, Magenau A, Boneberg EM, Gaus K, Viola A,
Giebel B, Illges H: Flotillins are involved in the polarization of primitive
and mature hematopoietic cells. PLoS ONE 2009, 4:e8290.
15. Giri B, Dixit VD, Ghosh MC, Collins GD, Khan IU, Madara K, Weeraratna AT,
Taub DD: CXCL12-induced partitioning of flotillin-1 with lipid rafts plays
a role in CXCR4 function. Eur J Immunol 2007, 37:2104-2116.
16. Rossy J, Schlicht D, Engelhardt B, Niggli V: Flotillins interact with PSGL-1 in
neutrophils and, upon stimulation, rapidly organize into membrane
domains subsequently accumulating in the uropod. PLoS ONE 2009, 4:
e5403.
17. Ludwig A, Otto GP, Riento K, Hams E, Fallon PG, Nichols BJ: Flotillin
microdomains interact with the cortical cytoskeleton to control uropod
formation and neutrophil recruitment. J Cell Biol 2010, 191:771-781.
18. Langhorst MF, Solis GP, Hannbeck S, Plattner H, Stuermer CA: Linking
membrane microdomains to the cytoskeleton: regulation of the lateral
mobility of reggie-1/flotillin-2 by interaction with actin. FEBS Lett 2007,
581:4697-4703.
19. Yoshinaga-Ohara N, Takahashi A, Uchiyama T, Sasada M: Spatiotemporal
regulation of moesin phosphorylation and rear release by rho and
serine/threonine phosphatase during neutrophil migration. Exp Cell Res
2002, 278:112-122.
20. Bubb MR, Spector H, Beyer BB, Fosen KM: Effects of jasplakinolide on the
kinetics of actin polymerization. J Biol Chem 2000, 275:5163-5170.
21. Jacobelli J, Friedman RS, Conti MA, Lennon-Dumenil AM, Piel M,
Sorensen C, Adelstein RS, Krummel MF: Confinement-optimized three-
dimensional T cell amoeboid motility is modulated via myosin IIA-
regulated adhesions. Nature Immunology 2010, 11:953-961.
22. Solis GP, Hoegg M, Munderloh C, Schrock Y, Malaga-Trillo E, Rivera-Milla E,
Stuermer CA: Reggie/flotillin proteins are organized into stable tetramers
in membrane microdomains. Biochem J 2007, 403:313-322.
23. Morrow IC, Rea S, Marin S, Prior IA, Prohaska R, Hancock JF, James DE,
Parton RG: Flotillin-1/reggie-2 traffics to surface raft domains via a novel
golgi-independent pathway. Identification of a novel membrane
targeting domain and a role for palmitoylation. J Biol Chem 2002,
277:48834-48841.
24. Neumann-Giesen C, Falkenbach B, Beicht P, Claasen S, Lüers G,
Stuermer CA, Herzog V, Tikkanen R: Membrane and raft association of
reggie-1/flotillin-2: role of myristoylation, palmitoylation and
oligomerization and induction of filopodia by overexpression. Biochem J
2004, 378:509-518.
25. Kolega J: Phototoxicity and photoinactivation of blebbistatin in UV and
visible light. Biochem Biophys Res Commun 2004, 320:1020-1025.
26. Neumann-Giesen C, Fernow I, Amaddii M, Tikkanen R: Role of EGF-induced
tyrosine phosphorylation of reggie-1/flotillin-2 in cell spreading and
signaling to the actin cytoskeleton. J Cell Sci 2007, 120:395-406.
27. Seveau S, Eddy RJ, Maxfield FR, Pierini LM: Cytoskeleton-dependent
membrane domain segregation during neutrophil polarization. Mol Biol
Cell 2001, 12:3550-3562.
28. Gómez-Moutón C, La Calle RA, Mira E, Jiménez-Baranda S, Barber DF, et al:
Dynamic redistribution of raft domains as an organizing platform for
signaling during cell chemotaxis. J Cell Biol 2004, 164:759-768.
29. Viola A, Gupta N: Tether and trap: regulation of membrane-raft dynamics
by actin-binding proteins. Nat Rev Immunol 2007, 7:889-896.
30. Vicente-Manzanares M, Cabrero JR, Rey M, Pérez-Martínez M, Ursa A, Itoh K,
Sánchez-Madrid F: A role for Rho-p160 Rho coiled-coil kinase axis in the
chemokine stromal cell-derived factor-1 -induced lymphocyte
actomyosin and microtubular organization and chemotaxis. J Immunol
2002, 168:400-410.
31. Bardi G, Niggli V, Loetscher P: Rho-kinase is required for CCR7-mediated
polarization and chemotaxis of T-lymphocytes. FEBS Lett 2003, 542:79-83.
32. Smith A, Bracke M, Leitinger B, Porter JC, Hogg N: LFA-1-induced T cell
migration on ICAM-1 involves regulation of MLCK-mediated attachment
and ROCK-dependent detachment. J Cell Sci 2003, 116:3123-3133.
33. Jacobelli J, Chmura SA, Buxton DB, Davis MM, Krummel MF: A single class
II myosin modulates T cell motility and stopping, but not synapse
formation. Nat Immunol 2004, 5:531-538.
34. Samaniego R, Sanchez-Martin L, Estecha A, Sanchez-Mateos P: Rho/ROCK
and myosin II control the polarized distribution of endocytic clathrin
structures at the uropod of moving T lymphocytes. J Cell Sci 2007,
120:3534-3543.
35. Cooper KM, Bennin DA, Huttenlocher A: The PCH family member proline-
serine-threonine phosphatase-interacting protein 1 targets to the
leukocyte uropod and regulates directed cell migration. Mol Biol Cell
2008, 19:3180-3191.
36. Yoo SK, Deng Q, Cavnar PJ, Wu YI, Hahn KM, Huttenlocher A: Differential
regulation of protrusion and polarity by PI(3)K during neutrophil motility
in live zebrafish. Dev Cell 2010, 18:226-236.
37. Lee JH, Katakai T, Hara T, Gonda H, Sugai M, Shimizu A: Roles of p-ERM
and Rho-ROCK signaling in lymphocyte polarity and uropod formation. J
Cell Biol 2004, 187:327-337.
38. Hansen GC, Nichols BJ: Molecular mechanisms of clathrin-independent
endocytosis. J Cell Sci 2009, 122:1713-1721.
39. Ait-Slimane T, Galmes R, Trugnan G, Maurice M: Basolateral internalization
of GPI-anchored proteins occurs via a clathrin-independent flotillin-
dependent pathway in polarized hepatic cells. Mol Biol Cell 2009,
20:3792-3800.
doi:10.1186/1471-2121-12-28
Cite this article as: Affentranger et al.: Dynamic reorganization of
flotillins in chemokine-stimulated human T-lymphocytes. BMC Cell
Biology 2011 12:28.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Affentranger et al. BMC Cell Biology 2011, 12:28
http://www.biomedcentral.com/1471-2121/12/28
Page 17 of 17